Research Article | Open Access
Chondrocyte Differentiation of Human Endometrial Gland-Derived MSCs in Layered Cell Sheets
Recently, regenerative medicine using engineered three-dimensional (3D) tissues has been focused. In the fields of cell therapy and regenerative medicine, mesenchymal stem cells (MSCs) are attractive autologous cell sources. While, in bioengineered tissues, a 3D environment may affect the differentiation of the stem cells, little is known regarding the effect of 3D environment on cellular differentiation. In this study, MSC differentiation in in vitro 3D tissue models was assessed by human endometrial gland-derived MSCs (hEMSCs) and cell sheet technology. hEMSC sheets were layered into cell-dense 3D tissues and were cultured on porous membranes. The tissue sections revealed that chondrocyte-like cells were found within the multilayered cell sheets even at 24 h after layering. Immunostainings of chondrospecific markers were positive within those cell sheet constructs. In addition, sulfated glycosaminoglycan accumulation within the tissues increased in proportion to the numbers of layered cell sheets. The findings suggested that a high cell density and hypoxic environment in 3D tissues by layering cell sheets might accelerate a rapid differentiation of hEMSCs into chondrocytes without the help of chondro-differentiation reagents. These tissue models using cell sheets would give new insights to stem cell differentiation in 3D environment and contribute to the future application of stem cells to cartilage regenerative therapy.
Cell-based regenerative therapy has a potential for treating diseased/defective tissues and organs that are unable to be cured by conventional medical treatments including medicines and surgeries. Regenerative medicine using artificial tissue fabricated by scaffold-based tissue engineering has appeared as the second-generation therapy, and the clinical trials have been performed [1–4]. Scaffold-based tissue engineering has been currently based on a concept that three-dimensional (3D) biomaterials including polycaprolactone, collagen, gelatin, and so forth are used as an alternative to extracellular matrix (ECM) and cells are seeded into the materials.
Our laboratory has developed a scaffolds-free tissue engineering, “cell sheet engineering,” using temperature-responsive culture surfaces, which can control the attachment and detachment of living cells by simple temperature changes [5–7]. Three-dimensional cell-sheet constructs fabricated by the technology are clearly cell-dense, and their functional junctions are tightly formed among cells within the tissues [8–10]. For example, cardiomyocytes in engineered 3D myocardial tissues coupled electrically and functionally via gap junctions, and the tissues can beat synchronously like the real heart [8, 10]. In addition, the authors have recently found that thicker tissue (the thickness of sextuple-layered cell sheets: more than 100 μm) was able to be fabricated by a 3D-tissue culture method on porous membrane, where the thickness limitation of viable tissue depends on oxygen and nutrient gradients could be avoided . The circumstances of the thicker cell-dense 3D tissue culture are thought to be quite different from those of monolayer two-dimensional (2D) culture.
Mesenchymal stem cells (MSCs), which are a type of somatic stem cells, are an attractive autologous cell source for cell-based regenerative therapy, since they have a strong ability to proliferate actively in vitro and differentiate into various cells including chondrocytes, osteocytes, adipocytes, skeletal myoblasts, cardiomyocytes, and so forth, with the treatments of optimal bioactive factors including cytokines or their surrounded circumstances [11–17]. In addition, those cells can be isolated easily from various tissues including bone marrow, adipose tissue, umbilical cord, amniotic fluid, peripheral blood, and so forth. Recently, some stem cells, which express surface antigens similar to those of bone marrow-derived MSCs, are isolated from human menstrual blood and endometrial gland .
Cells within a 3D culture system are reported to be significantly different from those in a 2D culture system in terms of their morphology, cell-cell interactions, surrounding ECM, proliferation rates, differentiation, and so forth. [19–21]. These differences may be affected by their different circumstances of oxygen, nutrients, growth factors, cell-cell and cell-matrix interactions, and so forth. Although, in 2D culture, oxygen tension, and the concentrations of nutrients and growth factors are unusually high, in 3D culture, cells are subject to multiple stimuli, namely, cytokines, growth factors, and proteins secreted from surrounding cells . Cells are also affected by biochemical and mechanical interactions with ECM as well as direct cell-cell contacts .
In this study, cell-dense thicker 3D tissues were fabricated from human endometrial gland-derived MSC (hEMSC) sheets, and the differentiation of the stem cells within the tissue was assessed and analyzed.
2. Materials and Methods
2.1. Preparation and Layering of hEMSC Sheets
hEMSCs, which showed an adherent spindle-shape morphology, were cultured in Dulbecco’s modified Eagle’s medium (DMEM) (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% fetal bovine serum (FBS) (Japan Bio Serum, Nagoya), 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA, USA) [9, 18, 23]. hEMSC sheets were fabricated as previous reports [9, 10, 23]. Briefly, hEMSCs (1.0 × 106 cells) were cultured on a 35 mm diameter temperature-responsive culture dish (Upcell, CellSeed, Tokyo, Japan) for 4 days at 37°C, and the culture dish was placed in a CO2 incubator at 20°C. A hEMSC sheet detached itself spontaneously within 30 min. The cell sheets were layered on a cell-culture insert (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) having a track-etched PET membrane (the membrane pore size: 1 μm), because a previous report has shown that the cultivation of layered cell sheets on the porous membranes induces the improvement of cell viability and the fabrication of thicker tissues than that on normal culture surfaces . The insert was set in a 6-well cell-culture insert companion plate (Becton, Dickinson and Company). Harvested cell sheets from temperature-responsive culture surfaces were layered on the membrane as described in previous reports . Briefly, a cell sheet with media was gently aspirated into the tip of a pipette and was transferred onto the membrane, which was pretreated with FBS for more than 30 min. After the first cell sheet was spread, the media were aspirated, and the plate was incubated at 37°C for allowing the cell sheet to fully adhere to the membrane. To layer hEMSC sheets, the second sheet recovered from another temperature-responsive culture dish was layered onto the first cell sheet. By the same fashion, recovered cell sheets were successfully layered up to sextuple layer. The multilayered cell sheets were cultured for 24 h in a humidified atmosphere of 5% CO2 at 37°C with 2 mL medium (DMEM supplemented with 10% FBS, 1% penicillin/streptomycin) in both insert and well.
2.2. Histological Analysis
After being incubated for 24 h, multilayered cell sheets on the porous membranes were fixed with 4% paraformaldehyde solution (Muto Pure Chemicals, Tokyo, Japan) at least for 1 day. Specimens were embedded in paraffin, sectioned, and stained with hematoxylin and eosin. Prepared specimens were observed by an optical microscope (ECLIPSE TE2000-U) (Nikon, Tokyo, Japan).
For detecting chondrocyte differentiation, the deparaffinized sections were also stained with the antibodies of chondrospecific markers: (1) monoclonal anti-human type II collagen (Cosmo Bio, Tokyo, Japan), which were diluted at 1 : 100 and (2) hyaluronan-binding protein (Seikagaku Corporation, Tokyo, Japan), which were diluted at 1 : 200. The detections of the immuneoreactions were enhanced by a CSA ll Biotin-free Tyramide Signal Amplication System (Dako Cytomation, Glostrup, Denmark) according to the manufacturer-suggested protocol. Hematoxylin was used for nuclear counterstaining. Prepared specimens were observed by the optical microscope.
2.4. Measurement of Sulfated Glycosaminoglycan Accumulation within Layered hEMSC Sheets
The accumulation of sulfated glycosaminoglycan (sGAG), which is the constituent of ECM in cartilage tissues, within layered hEMSC sheets was quantitated by a commercially available kit (Seikagaku Biobusiness, Tokyo, Japan), which is a colorimetric determination method using 1,9-dimethylmethylene blue.
2.5. Data Analysis
Data were expressed as the mean ± SD. Dunnett’s test was performed to compare two groups.
3. Results and Discussion
3.1. Morphological Analysis of the Layered hEMSC Sheets
hEMSC sheets were layered into 3D tissues onto a porous membrane, and the differentiation kinetics of the stem cells within the cell sheet constructs were histologically examined. At 24 h after the cultivation of layered hEMSC sheets, the constructs were observed cross-sectionally. Because, after detaching from temperature-responsive culture dishes, a cell sheet shrunk horizontally due to the cytoskeletal tensile reorganization, a single-layer cell sheet consisted of several cell-layers, and the thickness of the cell sheet became more than 25 μm (Figure 1). With increasing the number of stratified cell sheets, the thicknesses of the layered cell sheets increased as shown in Figure 1. The thicknesses of more than triple-layered cell sheets were more than 100 μm, and those cell layer tissues were clearly cell dense. Some characteristic cells were found within the multilayered cell-sheet constructs and resembled differentiated chondrocytes (Figure 1). Many chondrocyte-like cells were found within more than quadruple-layered cell-sheet constructs (Figures 1 and 2). After the cell sheet layering, hEMSCs might differentiate into chondrocytes very rapidly (24-h cultivation) within the multilayered cell sheet constructs. On the other hand, in single-, double-, triple-layered cell-sheet constructs, similar cell structures were observed (Figure 1).
(a) Single layer
(b) Double layer
(c) Triple layer
(d) Quadruple layer
(e) Quintuple layer
(f) Sextuple layer
3.2. Expression of Chondrospecific Markers in Layered hEMSC Sheets
The expressions of chondrospecific markers in cells within 3D cell-sheet tissues fabricated by layering hEMSC sheets were examined by an immunohistological analysis. While, especially, the expression of type II collagen was strongly detected in multilayered (more than quadruple-layered) cell-sheet constructs, in all cell-sheet constructs including a single-layer cell sheet, the expression was detected (Figure 3(a)). Hyaluronan-binding protein was also expressed in all layered cell-sheets constructs (Figure 3(b)). These results confirmed the chondro-differentiation of hEMSCs within the multilayered cell sheet constructs. At the same time, the chondrocyte differentiation was suggested to occur in all cell-sheet constructs including a single-layer cell sheet. While those chondrospecific markers-positive cells were detected in the tissue constructs even at 24 h after the layering without the adding of chondro-differentiation reagents, no further increases were detected by further cultivation (data not shown). Those results were well consistent with that of morphological analysis (data not shown).
(a) Type II collagen
(b) Hyaluronan-binding protein
sGAG accumulation within the constructs was measured quantitatively. The sGAG accumulations within cell sheets enhanced during a 24 h cultivation after detachment, and with increasing the number of stratified cell sheets (from single to sextuple), total sGAG accumulation tended to increase (Figure 4).
In this study, in vitro chondrocyte differentiation from hEMSCs within 3D tissue constructs fabricated by layering the stem cell sheets was shown. Articular cartilage has a poor ability for self-regeneration after the defective/injury, because it shows a low cell density and has limited blood supply. Various therapies including chondrocyte transplantation and tissue engineering methodology using 3D scaffolds have been performed clinically for regenerating articular cartilage damage [3, 24, 25]. For those therapies, autologous chondrocytes are isolated from the tissues and used as a cell source. At the same time, bone marrow-derived and adipose tissue-derived MSCs were also used as other autologous cell sources. MSCs differentiate into chondrocytes in the transplanted area in vivo and the implantation induces good therapeutic effects in animal models, and the therapies using bone marrow-derived MSCs have been clinically performed [17, 26–31]. This study suggested that hEMSCs as well as bone marrow-derived and adipose tissue-derived MSCs should be useful as a cell source for cartilage regenerative medicine. In addition, the chondrocyte differentiation of hEMSCs in 3D tissues fabricated by layering cell sheets was rapid (24 h cultivation after layering). Normally, in vitro differentiation from MSCs into chondrocytes is taken about for approximately three weeks by a conventional method . Transplantation after the short term in vitro cultivation of layered hEMSC sheets into defective cartilage tissues might induce a stronger therapeutic effect than that of undifferentiated stem cells. On the other hand, although the expressions of chondrospecific markers were detected in the layered cell-sheet constructs even at 24 h, no further increases were detected by further cultivation (data not shown).
Cell sheet technology has now been applied to the regeneration of various damaged tissues, and clinical trials have been ready performed in several tissues including cornea epithelial, myocardial, esophageal, and periodontal tissues [33–37]. Because confluent cells on a temperature-responsive culture surface can be harvested as an intact and contiguous cell sheet by simply reducing the temperature without protease treatment, cell-cell junctions and ECM components mediating cell adhesion, which are susceptible to protease treatment, are preserved intact in the cell sheet [38–40]. Because cell sheets maintain cell-cell junctions and ECM components, cell-dense and functional 3D tissues can be easily fabricated by simply layering cell sheets without any scaffold, and the engineered tissues can also adhere directly to the host tissues without suturing . More recently, the technology has been successfully applied to repair/regenerate the damaged cartilage tissue [42–46] and the clinical study has also been started. In in vivo and ex vivo experiments, multilayered human articular chondrocyte sheets were found to adhere firmly to rabbit and porcine cartilage tissues [42, 45]. The higher expressions of cell adhesion molecules, fibronectin and integrin α10 were detected in the multilayered chondrocyte sheets than those in monolayer chondrocytes [42, 44]. Layered chondrocyte sheets, which express highly those cell adhesion molecules, on temperature-responsive culture surfaces can be harvested by simply reducing culture temperature. In addition, scanning electron microscopical observation showed that the basal surface of the chondrocyte sheet had a completely different surface texture from that of the top of the sheet, and in other words, compared with the top surface, the bottom surface showed a smooth arrangement of the accumulated ECM with a parallel pattern . The good adhesiveness of layered chondrocyte sheets onto the tissues might be related to the preservation of those molecules as well as the smooth arrangement of the basal surface, which more resembles normal cartilage surface than the top side of the cell sheet. Furthermore, while human articular chondrocytes is known to lose their chondrocyte phenotype during 2D cultivation , in the multilayered chondrocyte sheets, the expressions of chondrospecific markers, namely, type II collagen, SOX9, Aggrecan, are significantly increased in comparison to those in 2D cultured chondrocytes or in a single chondrocyte sheet, indicating that a multilayered chondrocyte sheet has a natural cartilage phenotype [42, 44]. The maintenance of chondrogenic phenotype might be related to the 3D environment of layered cell sheets. This study showed that an environment within 3D tissues fabricated by layering cell sheets might accelerate the differentiation of hEMSCs into chondrocytes. In the original and general chondrocyte differentiation methods from MSCs, the cells are collected into high cell-density pellets to induce a round shape and treated with cytokines/reagents described above [11–13]. In this study, the high cell density and hypoxic environment within 3D tissues might promote the chondrocyte differentiation of MSCs and the maintenance of chondrogenic phenotypes. In vitro cultivation under hypoxia has been reported to promote the restoration of chondrogenic phenotypes in human articular chondrocytes and enhance the chondrogenic differentiation of human bone marrow-derived MSCs [48, 49]. A previous report using a fiber-optical oxygen microsensor has showed that the oxygen concentrations between single- or multilayered EMSC sheets, and the insert membrane are quickly decreased, suggesting a hypoxia condition within layered cell sheets including single-layer cell sheets, whose thicknesses are more than 25 μm . The elucidation of the detail molecular mechanisms of chondrocyte differentiation within 3D tissues should contribute to the establishment of novel and effective chondrocyte differentiation methods from MSCs and the fabrication of valuable 3D cartilage tissue. Layered cell sheets containing chondrocytes differentiated from hEMSCs on temperature-responsive culture surfaces were able to be harvested with preserving cell adhesive molecules on the cell surfaces and would contribute to cartilage tissue engineering and regenerative medicine.
This study assessed and analyzed human EMSC differentiation in vitro 3D tissue models using cell sheet technology. This study suggested that a high cell density and hypoxic environment in 3D tissues fabricated by layering cell sheets might accelerate a rapid differentiation of MSCs into chondrocytes without the help of chondro-differentiation reagents. These 3D tissue models using cell sheets would give new insights to stem cell differentiation in 3D environment and contribute to the future application of the stem cells to cartilage regenerative therapy.
Waki Sekine and Yuji Haraguchi contributed equally to this study.
T. Shimizu and M. Yamato are consultants for CellSeed, Inc. T. Okano is an investor in CellSeed, Inc., and an investor/developer designated on the patent for temperature-responsive culture surfaces.
We appreciate the useful comments and technical criticism from Professor Ung-il Chung (Center for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo) and Dr. Norio Ueno (Institute of Advanced Biomedical Engineering and Science, TWIns, Tokyo Women’s Medical University). This work was supported by grants from the Global Center of Excellence Program, Multidisciplinary Education and Technology and Research Center for Regenerative Medicine (MERCREM), and Formation of Innovation Center for Fusion of Advanced Technologies in the Special Coordination Funds for Promoting Science and Technology “Cell Sheet Tissue Engineering Center (CSTEC)” from the Ministry of Education, Culture, Sports Science, and Technology (MEXST), Japan, the Japan Society for the Promotion of Science (JSPS) through the “Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program),” initiated by the Council for Science and Technology Policy (CSTP).
- T. Shinoka and C. Breuer, “Tissue-engineered blood vessels in pediatric cardiac surgery,” Yale Journal of Biology and Medicine, vol. 81, no. 4, pp. 161–166, 2008.
- J. C. Chachques, “Cellular cardiac regenerative therapy in which patients?” Expert Review of Cardiovascular Therapy, vol. 7, no. 8, pp. 911–919, 2009.
- J. Iwasa, L. Engebretsen, Y. Shima, and M. Ochi, “Clinical application of scaffolds for cartilage tissue engineering,” Knee Surgery, Sports Traumatology, Arthroscopy, vol. 17, no. 6, pp. 561–577, 2009.
- K. Lee, C. K. Chan, N. Patil, and S. B. Goodman, “Cell therapy for bone regeneration-bench to bedside,” Journal of Biomedical Materials Research B, vol. 89, no. 1, pp. 252–263, 2009.
- N. Yamada, T. Okano, H. Sakai et al., “Thermo-responsive polymeric surface: control of attachment and detachment of cultured cells,” Makromolecular Rapid Communications, vol. 11, no. 11, pp. 571–576, 1990.
- T. Okano, N. Yamada, H. Sakai, and Y. Sakurai, “A novel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly(N-isopropylacrylamide),” Journal of Biomedical Materials Research, vol. 27, no. 10, pp. 1243–1251, 1993.
- Y. Kumashiro, M. Yamato, and T. Okano, “Cell attachment-detachment control on temperature-responsive thin surfaces for novel tissue engineering,” Annals of Biomedical Engineering, vol. 38, no. 6, pp. 1977–1988, 2010.
- T. Shimizu, H. Sekine, J. Yang et al., “Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues,” FASEB Journal, vol. 20, no. 6, pp. 708–710, 2006.
- W. Sekine, Y. Haraguchi, T. Shimizu, A. Umezawa, and T. Okano, “Thickness limitation and cell viability of multi-layered cell sheets and overcoming the diffusion limit by a porous-membrane culture insert,” Journal of Biochips & Tissue Chips, vol. S2, 2011.
- Y. Haraguchi, T. Shimizu, T. Sasagawa et al., “Fabrication of functional three-dimensional tissues by stacking cell sheets in vitro,” Nature Protocols, vol. 7, no. 5, pp. 850–858, 2012.
- A. I. Caplan, “Mesenchymal stem cells,” Journal of Orthopaedic Research, vol. 9, no. 5, pp. 641–650, 1991.
- D. J. Prockop, “Marrow stromal cells as stem cells for nonhematopoietic tissues,” Science, vol. 276, no. 5309, pp. 71–74, 1997.
- M. F. Pittenger, A. M. Mackay, S. C. Beck et al., “Multilineage potential of adult human mesenchymal stem cells,” Science, vol. 284, no. 5411, pp. 143–147, 1999.
- A. I. Caplan, “MSCs in regenerative medicine,” in Principles of Regenerative Medicine, A. Atala, R. Lanza, J. A. Thomson, and R. Nerem, Eds., Academic Press, London, UK, 2nd edition, 2011.
- S. Wang, X. Qu, and R. C. Zhao, “Mesenchymal stem cells hold promise for regenerative medicine,” Frontiers of Medicine in China, vol. 5, no. 4, pp. 372–378, 2011.
- S. H. Choi, S. Y. Jung, S. M. Kwon, and S. H. Baek, “Perspectives on stem cell therapy for cardiac regeneration. Advances and challenges,” Circulation Journal, vol. 76, no. 6, pp. 1307–1312, 2012.
- L. Wu , X. Cai, S. Zhang, M. Karperien, and Y. Lin, “Regeneration of articular cartilage by adipose tissue derived mesenchymal stem cells: perspectives from stem cell biology and molecular medicine,” Journal of Cellulare Physiology, vol. 228, no. 5, pp. 938–944, 2013.
- N. Hida, N. Nishiyama, S. Miyoshi et al., “Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells,” Stem Cells, vol. 26, no. 7, pp. 1695–1704, 2008.
- A. Abbott, “Biology's new dimension,” Nature, vol. 424, no. 6951, pp. 870–872, 2003.
- Editorial, “Goodbye, flat biology?” Nature, vol. 424, no. 6951, p. 861, 2003.
- K. S. M. Smalley, M. Lioni, and M. Herlyn, “Life isn't flat: taking cancer biology to the next dimension,” In Vitro Cellular and Developmental Biology, vol. 42, no. 8-9, pp. 242–247, 2006.
- J. El-Ali, P. K. Sorger, and K. F. Jensen, “Cells on chips,” Nature, vol. 442, no. 7101, pp. 403–411, 2006.
- Y. Haraguchi, W. Sekine, T. Shimizu et al., “Development of a new assay system for evaluating the permeability of various substances through three-dimensional tissue,” Tissue Engineering C, vol. 16, no. 4, pp. 685–692, 2010.
- M. Brittberg, A. Lindahl, A. Nilsson, C. Ohlsson, O. Isaksson, and L. Peterson, “Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation,” New England Journal of Medicine, vol. 331, no. 14, pp. 889–895, 1994.
- M. Ochi, Y. Uchio, K. Kawasaki, S. Wakitani, and J. Iwasa, “Transplantation of cartilage-like tissue made by tissue engineering in the treatment of cartilage defects of the knee,” Journal of Bone and Joint Surgery B, vol. 84, no. 4, pp. 571–578, 2002.
- S. Wakitani, T. Goto, S. J. Pineda et al., “Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage,” Journal of Bone and Joint Surgery A, vol. 76, no. 4, pp. 579–592, 1994.
- S. Wakitani, K. Imoto, T. Yamamoto, M. Saito, N. Murata, and M. Yoneda, “Human autologous culture expanded bone marrow-mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees,” Osteoarthritis and Cartilage, vol. 10, no. 3, pp. 199–206, 2002.
- S. Wakitani, T. Mitsuoka, N. Nakamura, Y. Toritsuka, Y. Nakamura, and S. Horibe, “Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports,” Cell Transplantation, vol. 13, no. 5, pp. 595–600, 2004.
- S. Wakitani, M. Nawata, K. Tensho, T. Okabe, H. Machida, and H. Ohgushi, “Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in five knees,” Journal of Tissue Engineering and Regenerative Medicine, vol. 1, no. 1, pp. 74–79, 2007.
- T. Matsumoto, T. Okabe, T. Ikawa et al., “Articular cartilage repair with autologous bone marrow mesenchymal cells,” Journal of Cellular Physiology, vol. 225, no. 2, pp. 291–295, 2010.
- S. E. Bulman, V. Barron, C. M. Coleman, S. E. Bulman, and F. Barry, “Enhancing the mesenchymal stem cell therapeutic response: cell localization and support for cartilage repair,” Tissue Engineering Part B Review, vol. 19, no. 1, pp. 58–68, 2013.
- D. C. Colter, I. Sekiya, and D. J. Prockop, “Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 14, pp. 7841–7845, 2001.
- K. Nishida, M. Yamato, Y. Hayashida et al., “Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium,” New England Journal of Medicine, vol. 351, no. 12, pp. 1187–1196, 2004.
- C. Burillon, L. Huot, V. Justin et al., “Cultured autologous oral mucosal epithelial cell-sheet (CAOMECS) transplantation for the treatment of corneal limbal epithelial stem cell deficiency,” Investigation Ophthalmology Visual Science, vol. 53, no. 3, pp. 1325–1331, 2012.
- T. Ohki, M. Yamato, M. Ota et al., “Prevention of esophageal stricture after endoscopic submucosal dissection using tissue-engineered cell sheets,” Gastroenterology, vol. 143, no. 3, pp. 582–588, 2012.
- Y. Sawa, S. Miyagawa, T. Sakaguchi et al., “Tissue engineered myoblast sheets improved cardiac function sufficiently to discontinue LVAS in a patient with DCM: report of a case,” Surgery Today, vol. 42, no. 2, pp. 181–184, 2012.
- T. Iwata, K. Washio, T. Yoshida et al., “Cell sheet engineering and its application for periodontal regeneration,” Journal of Tissue Engineering and Regenerative Medicine, 2013.
- A. Kushida, M. Yamato, C. Konno , A. Kikuchi, Y. Sakurai, and T. Okano, “Decrease in culture temperature releases monolayer endothelial cell sheets together with deposited fibronectin matrix from temperature-responsive culture surface,” Journal of Biomedical Materials Research, vol. 45, no. 4, pp. 355–362, 1999.
- K. Nishida, M. Yamato, Y. Hayashida et al., “Functional bioengineered corneal epithellial sheet grafts from corneal stem cells expanded ex vivo on a temperature-responsive cell culture surface,” Transplantation, vol. 77, no. 3, pp. 379–385, 2004.
- K. Ohashi, T. Yokoyama, M. Yamato et al., “Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets,” Nature Medicine, vol. 13, no. 7, pp. 880–885, 2007.
- Y. Haraguchi, T. Shimizu, M. Yamato, and T. Okano, “Concise review: cell therapy and tissue engineering for cardiovascular disease,” Stem Cells Translational Medicine, vol. 1, no. 2, pp. 136–141, 2012.
- N. Kaneshiro, M. Sato, M. Ishihara, G. Mitani, H. Sakai, and J. Mochida, “Bioengineered chondrocyte sheets may be potentially useful for the treatment of partial thickness defects of articular cartilage,” Biochemical and Biophysical Research Communications, vol. 349, no. 2, pp. 723–731, 2006.
- M. Sato, M. Ishihara, K. Furukawa et al., “Recent technological advancements related to articular cartilage regeneration,” Medical and Biological Engineering and Computing, vol. 46, no. 8, pp. 735–743, 2008.
- G. Mitani, M. Sato, J. I. K. Lee et al., “The properties of bioengineered chondrocyte sheets for cartilage regeneration,” BMC Biotechnology, vol. 9, article 17, 2009.
- G. Ebihara, M. Sato, M. Yamato et al., “Cartilage repair in transplanted scaffold-free chondrocyte sheets using a minipig model,” Biomaterials, vol. 33, no. 15, pp. 3846–3851, 2012.
- M. Kokubo, M. Sato, M. Yamato et al., “Characterization of chondrocyte sheets prepared using a co-culture method with temperature-responsive culture inserts,” Journal of Tissue Engineering and Regenerative Medicine, 2013.
- F. Dell'Accio, C. De Bari, and F. P. Luyten, “Microenvironment and phenotypic stability specify tissue formation by human articular cartilage-derived cells in vivo,” Experimental Cell Research, vol. 287, no. 1, pp. 16–27, 2003.
- K. Schrobback, T. J. Klein, R. Crawford, Z. Upton, J. Malda, and D. I. Leavesley, “Effects of oxygen and culture system on in vitro propagation and redifferentiation of osteoarthritic human articular chondrocytes,” Cell and Tissue Research, vol. 347, no. 3, pp. 649–663, 2012.
- B. D. Markway, G.-K. Tan, G. Brooke, J. E. Hudson, J. J. Cooper-White, and M. R. Doran, “Enhanced chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells in low oxygen environment micropellet cultures,” Cell Transplantation, vol. 19, no. 1, pp. 29–42, 2010.
Copyright © 2013 Waki Sekine et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.